b-Arrestins in the Immune System - Progress in Molecular Biology and Translational Science - page 378

77. McCormick PJ, Segarra M, Gasperini P, Gulino AV, Tosato G. Impaired
recruitment of Grk6 and beta-arrestin 2 causes delayed internalization and desensi-
tization of a WHIM syndrome-associated CXCR4 mutant receptor. PLoS One .
2009;4:e8102.
78. Minsaas L, Planaguma J, Madziva M, et al. Filamin a binds to CCR2B and regulates its
internalization. PLoS One . 2010;5:e12212.
79. Huttenrauch F, Nitzki A, Lin FT, Honing S, Oppermann M. Beta-arrestin binding to
CC chemokine receptor 5 requires multiple C-terminal receptor phosphorylation sites
and involves a conserved Asp-Arg-Tyr sequence motif. J Biol Chem . 2002;277:
30769 - 30777.
80. Huttenrauch F, Pollok-Kopp B, Oppermann M. G protein-coupled receptor kinases
promote phosphorylation and beta-arrestin-mediated internalization of CCR5 homo-
and hetero-oligomers. J Biol Chem . 2005;280:37503 - 37515.
81. Burns JM, Summers BC, Wang Y, et al. A novel chemokine receptor for SDF-1 and
I-TAC involved in cell survival, cell adhesion, and tumor development. J Exp Med .
2006;203:2201 - 2213.
82. Boldajipour B, Mahabaleshwar H, Kardash E, et al. Control of chemokine-guided cell
migration by ligand sequestration. Cell . 2008;132:463 - 473.
83. Hunyady L, Catt KJ. Pleiotropic AT1 receptor signaling pathways mediating physio-
logical and pathogenic actions of angiotensin II. Mol Endocrinol . 2006;20:953 - 970.
84. McAllister-Lucas LM, Ruland J, Siu K, et al. CARMA3/Bcl10/MALT1-dependent
NF-kappaB activation mediates angiotensin II-responsive inflammatory signaling in
nonimmune cells. Proc Natl Acad Sci USA . 2007;104:139 - 144.
85. Kohout TA, Lin FS, Perry SJ, Conner DA, Lefkowitz RJ. beta-Arrestin 1 and 2 dif-
ferentially regulate heptahelical receptor signaling and trafficking. Proc Natl Acad Sci
USA . 2001;98:1601 - 1606.
86. Hunton DL, Barnes WG, Kim J, et al. Beta-arrestin 2-dependent angiotensin II type 1A
receptor-mediated pathway of chemotaxis. Mol Pharmacol . 2005;67:1229- 1236.
87. Tohgo A, Pierce KL, Choy EW, Lefkowitz RJ, Luttrell LM. beta-Arrestin scaffolding
of the ERK cascade enhances cytosolic ERK activity but inhibits ERK-mediated tran-
scription following angiotensin AT1a receptor stimulation. J Biol Chem . 2002;

277:9429 - 9436.
88. Willoughby EA, Collins MK. Dynamic interaction between the dual specificity phos-
phatase MKP7 and the JNK3 scaffold protein beta-arrestin 2. J Biol Chem .

2005;280:25651 - 25658.
89. Hisada Y, Sugaya T, Yamanouchi M, et al. Angiotensin II plays a pathogenic role in
immune-mediated renal injury in mice. J Clin Invest . 1999;103:627- 635.
90. Nataraj C, Oliverio MI, Mannon RB, et al. Angiotensin II regulates cellular immune
responses through a calcineurin-dependent pathway. J Clin Invest . 1999;104:

1693- 1701.
91. Premont RT, Inglese J, Lefkowitz RJ. Protein kinases that phosphorylate activated
G protein-coupled receptors. FASEB J . 1995;9:175 - 182.
92. Goodman Jr OB, Krupnick JG, Santini F, et al. Beta-arrestin acts as a clathrin adaptor in
endocytosis of the beta2-adrenergic receptor. Nature . 1996;383:447 - 450.
93. Baillie GS, Sood A, McPhee I, et al. beta-Arrestin-mediated PDE4 cAMP phospho-
diesterase recruitment regulates beta-adrenoceptor switching from Gs to Gi. Proc Natl
Acad Sci USA . 2003;100:940 - 945.
94. Neuschafer-Rube F, Hermosilla R, Rehwald M, et al. Identification of a Ser/Thr clus-
ter in the C-terminal domain of the human prostaglandin receptor EP4 that is essential
for agonist-induced beta-arrestin1 recruitment but differs from the apparent principal
phosphorylation site. Biochem J . 2004;379:573 - 585.